136 related articles for article (PubMed ID: 35320247)
1. Positron emission tomography - computed tomography as a monitoring response tool in pre-fibrotic myelofibrosis: A case report.
Qamar Uz Zaman A; Hussain S; Zaheer R; Andleeb M; Raza S; Siddiqui T
J Pak Med Assoc; 2022 Mar; 72(3):564-566. PubMed ID: 35320247
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of 18F-FDG-PET/CT for monitoring myelofibrosis after allogeneic stem cell transplantation.
Derlin T; Büsche G; Kröger N
Nucl Med Rev Cent East Eur; 2015; 18(1):35-6. PubMed ID: 25633515
[TBL] [Abstract][Full Text] [Related]
3. Assessment of bone marrow inflammation in patients with myelofibrosis: an 18F-fluorodeoxyglucose PET/CT study.
Derlin T; Alchalby H; Bannas P; Veldhoen S; Apostolova I; Triviai I; Bengel FM; Kröger N
Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):696-705. PubMed ID: 25601337
[TBL] [Abstract][Full Text] [Related]
4. Myelofibrosis on F-18 FDG PET Imaging.
Burrell SC; Fischman AJ
Clin Nucl Med; 2005 Oct; 30(10):674. PubMed ID: 16166839
[TBL] [Abstract][Full Text] [Related]
5. The Manifestation of a Patient With Myelofibrosis in 68Ga-DOTA-FAPI-04 PET/CT Mimicking "Super Bone Imaging".
Li X; Zhao Q; Luo Q; Chen L; Huang Z
Clin Nucl Med; 2022 Dec; 47(12):1056-1058. PubMed ID: 36342793
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. Serial 18F-FDG PET for Monitoring Treatment Response After Allogeneic Stem Cell Transplantation for Myelofibrosis.
Derlin T; Alchalby H; Bannas P; Laqmani A; Ayuk F; Triviai I; Kreipe HH; Bengel FM; Kröger N
J Nucl Med; 2016 Oct; 57(10):1556-1559. PubMed ID: 27230931
[TBL] [Abstract][Full Text] [Related]
8. F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma.
Ak I; Gulbas Z
Ann Hematol; 2011 Jan; 90(1):81-7. PubMed ID: 20690019
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Importance of Bone Marrow Uptake on Baseline
Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
[TBL] [Abstract][Full Text] [Related]
10. Assessing Bone Marrow Activity in Patients with Myelofibrosis: Results of a Pilot Study of
Vercellino L; Ouvrier MJ; Barré E; Cassinat B; de Beco V; Dosquet C; Chevret S; Meignin V; Chomienne C; Toubert ME; Merlet P; Kiladjian JJ
J Nucl Med; 2017 Oct; 58(10):1603-1608. PubMed ID: 28360204
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
[TBL] [Abstract][Full Text] [Related]
12. (18)F-FDG PET/CT for detection of leukemic transformation in myelofibrosis.
Derlin T; Clauditz TS; Kröger N
Clin Nucl Med; 2015 Jun; 40(6):521-2. PubMed ID: 25674874
[TBL] [Abstract][Full Text] [Related]
13. [18F-FDG-PET/CT is effective in distinguishing myelofibrosis due to bone marrow infiltration of diffuse large B-cell lymphoma from triple-negative primary myelofibrosis].
Kumagai T; Satoh Y; Koshiishi M; Ooishi S; Sueki Y; Nakajima K; Mitsumori T; Kirito K
Rinsho Ketsueki; 2017; 58(3):228-232. PubMed ID: 28381690
[TBL] [Abstract][Full Text] [Related]
14. Characterizing the Bone Marrow Environment in Advanced-Stage Myelofibrosis during Ruxolitinib Treatment Using PET/CT and MRI: A Pilot Study.
Slot S; Lavini C; Zwezerijnen GJC; Boden BJH; Marcus JT; Huisman MC; Yaqub M; Barbé E; Wondergem MJ; Zijlstra JM; Zweegman S; Raijmakers PG
Tomography; 2023 Feb; 9(2):459-474. PubMed ID: 36960997
[TBL] [Abstract][Full Text] [Related]
15. "Cold" Spondylodiscitis on 18F-FDG PET/CT in a Patient With Myelofibrosis.
Rousseau E; Keu KV
Clin Nucl Med; 2016 Mar; 41(3):e156-8. PubMed ID: 26571440
[TBL] [Abstract][Full Text] [Related]
16. Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy.
Gheysens O; Thielemans S; Morscio J; Boeckx N; Goffin KE; Deroose CM; Sagaert X; Wlodarska I; Verhoef G; Dierickx D; Tousseyn T
Leuk Lymphoma; 2016 Oct; 57(10):2382-8. PubMed ID: 26854937
[TBL] [Abstract][Full Text] [Related]
17. The value of FDG PET/CT in the initial staging and bone marrow involvement of patients with multiple myeloma.
Sager S; Ergül N; Ciftci H; Cetin G; Güner SI; Cermik TF
Skeletal Radiol; 2011 Jul; 40(7):843-7. PubMed ID: 21229354
[TBL] [Abstract][Full Text] [Related]
18. Utility of Bone Marrow Biopsy and Aspirate for Staging of Diffuse Large B Cell Lymphoma in the Era of Positron Emission Tomography With 2-Deoxy-2-[Fluorine-18]fluoro-deoxyglucose Integrated With Computed Tomography.
Vishnu P; Wingerson A; Lee M; Mandelson MT; Aboulafia DM
Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):631-636. PubMed ID: 28684378
[TBL] [Abstract][Full Text] [Related]
19. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of
Lee JW; Choi JS; Lyu J; Lee SM
Lung Cancer; 2018 Apr; 118():41-47. PubMed ID: 29572001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
